Rosa LMM, Araújo Siega MR de. High-frequency migraine refractory to usual pharmacological treatment and antibody and responsive to full-spectrum cannabidiol: a case report. Headache Med [Internet]. 2022 Sep. 30 [cited 2024 Nov. 23];13(3):229-32. Available from: https://headachemedicine.com.br/index.php/hm/article/view/661